Urine peptidomic biomarkers for diagnosis of patients with systematic lupus erythematosus.

about

Diagnostic and prognostic tests in systemic lupus erythematosus.

P2860

Q49966463-69366C19-A3E7-4572-B97E-09978E4AF305

P2860

Urine peptidomic biomarkers for diagnosis of patients with systematic lupus erythematosus.

Item

http://www.wikidata.org/entity/Q53311622

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Urine peptidomic biomarkers fo ...... ystematic lupus erythematosus.

@en

Urine peptidomic biomarkers fo ...... ystematic lupus erythematosus.

@nl

type

Item

label

Urine peptidomic biomarkers fo ...... ystematic lupus erythematosus.

@en

Urine peptidomic biomarkers fo ...... ystematic lupus erythematosus.

@nl

prefLabel

Urine peptidomic biomarkers fo ...... ystematic lupus erythematosus.

@en

Urine peptidomic biomarkers fo ...... ystematic lupus erythematosus.

@nl

P1476

Urine peptidomic biomarkers fo ...... ystematic lupus erythematosus.

@en

P2093

L C Burkly

http://www.w3.org/2001/XMLSchema#string

M Pejchinovski

http://www.w3.org/2001/XMLSchema#string

R Wei

http://www.w3.org/2001/XMLSchema#string

W Mullen

http://www.w3.org/2001/XMLSchema#string

P2860

Remodelling the extracellular matrix in development and disease

Proteasix: a tool for automated and large-scale prediction of proteases involved in naturally occurring peptide generation

Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II

CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics.

Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine.

Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments

Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis.

Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data.

Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation.

P304

6-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0961203317707827

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Harald Mischak

Justyna Siwy

Michelle A. Petri

P577

2017-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28474961

http://www.w3.org/2001/XMLSchema#string

P932

6037307

http://www.w3.org/2001/XMLSchema#string

Urine peptidomic biomarkers for diagnosis of patients with systematic lupus erythematosus.

about

P2860

P2860

Urine peptidomic biomarkers for diagnosis of patients with systematic lupus erythematosus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932